Johnson & Johnson: Create Your Own Dividends
(WorldNews Health)

Johnson & Johnson (JNJ) recently experienced a great combination of positive events. The company just reported a blowout Q3 earnings report, where revenue and earnings estimates were exceeded. Johnson & Johnson is also benefiting from a reversal of the verdict of the talcum powder cancer risk case. Johnson & Johnson Stock is Overbought These news items drove the stock up over 3% in one day. The stock is now in an overbought condition with a stretched valuation. I expect the stock to pull back a little and or level off after this strong run up. I am not just talking about the strong one-day move. The stock is up about 25% over the past year. That was with the talc verdict looming...